Long-term complete remission of severe pemphigus vulgaris with monoclonal anti-CD20 antibody therapy and immunophenotype correlations [2]

Journal of the American Academy of Dermatology

Volumn 50, Issue 6, 2004, Pages 974-976

  España, Agustín ^a   Fernández Galar, Marta ^a   Lloret, Pedro ^a   Sánchez Ibarrola, Alfonso ^a   Panizo, Carlos ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CD20 ANTIBODY; DIPHENHYDRAMINE; PREDNISONE; RITUXIMAB;

ADULT; ANGINA PECTORIS; AZOOSPERMIA; BRONCHOSPASM; CASE REPORT; CORRELATION ANALYSIS; DISEASE SEVERITY; HUMAN; HYPERGLYCEMIA; IMMUNOPHENOTYPING; INTERSTITIAL PNEUMONIA; LETTER; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MUSCLE DISEASE; NEUTROPENIA; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; REMISSION; SIDE EFFECT; SKIN INFECTION;

EID: 2542490336     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2003.08.021     Document Type: Article

References (7)

1. Gonzalez A, España A, Lopez-Zabalza MJ, Pelacho B, Sánchez-Carpintero I, Santiago E, et al. Correlation between profile of circulating mononuclear cells and clinical manifestations in patients with pemphigus vulgaris. Autoimmunity 2000;32:115-28.
2. Maloney DG, Liles TM, Czerwinski DK, Waldichuk C, Rosenberg J, Grillo-Lopez A, et al. Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma. Blood 1994;84:2457-66.
3. Salopek TG, Logsetty S, Tredget EE. Anti-CD20 chimeric monoclonal antibody (rituximab) for the treatment of recalcitrant, life-threatening pemphigus vulgaris with implications in the pathogenesis of the disorder. J Am Acad Dermatol 2002;47:785-8.
4. Voog E, Morschauser F, Solal-Celigny P. Neutropenia in patients treated with rituximab. N Engl J Med 2003;348:2691-4.
5. Cerny T, Borisch B, Introna M, Johnson P, Rose AL. Mechanism of action of rituximab. Anticancer Drugs 2002;13(suppl 2):S3-10.
6. 1 phase of the cell cycle. J Immunol 1985;135:3795-801.
7. Slifka MK, Antia R, Whitmire JK, Ahmed R. Humoral immunity due to long-lived plasma cells. Immunity 1998;8:363-72.